LB-102

LB-102 · LB Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LB-102, covering 2025-10-22 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. [Phase 2]

See pricing